Abstract Background: The production of full length, biologically active proteins in mammalian cells is critical for a wide variety of purposes ranging from structural studies to preparation of subunit vaccines. Prior research has shown that Modified vaccinia virus Ankara encoding the bacteriophage T7 RNA polymerase (MVA-T7) is particularly suitable for high level expression of proteins upon infection of mammalian cells. The expression system is safe for users and 10-50 mg of full length, biologically active proteins may be obtained in their native state, from a few litres of infected cell cultures. Results: Here we report further improvements which allow an increase in the ease and speed of recombinant virus isolation, the scale-up of prote...
Many research projects in life sciences require purified biologically active recombinant protein. In...
BackgroundWe have previously described a five-plasmid HIV-1 vector system that utilises a codon-opti...
Cell-free protein production is a new technology that offers many advantages over conventional cell-...
Production of recombinant protein in mammalian cells is time-consuming, labor-intensive and costly. ...
AbstractModified vaccinia virus Ankara (MVA), a host range restricted and highly attenuated vaccinia...
AbstractThe vaccinia virus/bacteriophage T7 hybrid transient expression system employs a recombinant...
The vaccinia virus expression system was developed into a scaleable recombinant protein production p...
Recombinant production of complex eukaryotic proteins for structural analyses typically requires a p...
The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicke...
AbstractWe established a hybrid baculovirus-T7 RNA polymerase system for transient expression in mam...
Abstract Background In the last three decades, the Baculovirus expression vector system (BEV) has ev...
Conformational-complex membrane proteins (MPs) are vaccine/drug targets in many diseases, but drug a...
177–193 ppModified vaccinia virus Ankara (MVA) is employed widely as an experimental vaccine vector ...
There is increasing demand for high quality, biologically active recombinant proteins in awide range...
AbstractRNA virus vectors are attractive vaccine delivery agents capable of directing high-level gen...
Many research projects in life sciences require purified biologically active recombinant protein. In...
BackgroundWe have previously described a five-plasmid HIV-1 vector system that utilises a codon-opti...
Cell-free protein production is a new technology that offers many advantages over conventional cell-...
Production of recombinant protein in mammalian cells is time-consuming, labor-intensive and costly. ...
AbstractModified vaccinia virus Ankara (MVA), a host range restricted and highly attenuated vaccinia...
AbstractThe vaccinia virus/bacteriophage T7 hybrid transient expression system employs a recombinant...
The vaccinia virus expression system was developed into a scaleable recombinant protein production p...
Recombinant production of complex eukaryotic proteins for structural analyses typically requires a p...
The production of several viral vaccines depends on chicken embryo fibroblasts or embryonated chicke...
AbstractWe established a hybrid baculovirus-T7 RNA polymerase system for transient expression in mam...
Abstract Background In the last three decades, the Baculovirus expression vector system (BEV) has ev...
Conformational-complex membrane proteins (MPs) are vaccine/drug targets in many diseases, but drug a...
177–193 ppModified vaccinia virus Ankara (MVA) is employed widely as an experimental vaccine vector ...
There is increasing demand for high quality, biologically active recombinant proteins in awide range...
AbstractRNA virus vectors are attractive vaccine delivery agents capable of directing high-level gen...
Many research projects in life sciences require purified biologically active recombinant protein. In...
BackgroundWe have previously described a five-plasmid HIV-1 vector system that utilises a codon-opti...
Cell-free protein production is a new technology that offers many advantages over conventional cell-...